VOLITIONRX LTD — Director's Dealing 2016

Feb 9, 2016

SEC Form 4/A — Form 4/A

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-12-31

Reporting Person: Reynolds Cameron John (Director, President and CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	26858	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant (Right to Buy)	$2.6	2016-05-10	Common Stock (1429)	1429	Indirect
Stock Option (Right to Buy)	$3	2016-05-25	Common Stock (4000)	4000	Indirect
Stock Option (Right to Buy)	$3	2016-11-25	Common Stock (4000)	4000	Indirect
Stock Option (Right to Buy)	$4	2017-05-25	Common Stock (4000)	4000	Indirect
Stock Option (Right to Buy)	$4	2017-11-25	Common Stock (4000)	4000	Indirect
Stock Option (Right to Buy)	$5	2018-05-25	Common Stock (4000)	4000	Indirect
Stock Option (Right to Buy)	$5	2018-11-25	Common Stock (4000)	4000	Indirect
Stock Option (Right to Buy)	$2.5	2019-02-18	Common Stock (12500)	12500	Indirect
Stock Option (Right to Buy)	$3	2020-02-18	Common Stock (12500)	12500	Indirect
Stock Option (Right to Buy)	$4	2020-01-23	Common Stock (10000)	10000	Indirect

Footnotes

F1: The reporting person's wife owned the securities reported on Table I and the derivative securities reported on Table II on the date of their marriage, or acquired them after their marriage and prior to the date hereof, and they have not previously been reported on Form 4 by the reporting person.